Biogen, Inc.
$59.9M 36,001 recipients
Compare payment profiles
CMS Open Payments · Program Year 2024
Bayer Healthcare Pharmaceuticals Inc.
Bayer Healthcare Pharmaceuticals Inc. reported $58,008,095.74 across General Payments, Research, and Ownership to 146,928 physicians and teaching hospitals across 158,535 transactions.
- $58.0M Top 10% payer
- All-tracks total
- 158,535 Top 10% volume
- Transactions
- 146,928 Top 10% reach
- Recipients
- −$302.5K
- General Payments vs PY2023
Bayer Healthcare Pharmaceuticals Inc. reported $58,008,095.74 across all CMS Open Payments tracks (General + Research + Ownership) to 146,928 physicians and teaching hospitals in Program Year 2024 - ranking #43 of 1,925 reporting manufacturers (0.4% of the all-tracks industry total); General Payments alone were $11,461,679.87, averaging $394.81 per recipient.
How Bayer Healthcare Pharmaceuticals Inc.'s $58.0M all-tracks total breaks down
Bayer Healthcare Pharmaceuticals Inc.'s payment reach score
Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.
Overall reach score
A
98/100
Total payments
A
100/100
Transaction volume
A
100/100
Physician reach
A
100/100
Payment type diversity
A
90/100
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer bayer-healthcare-pharmaceuticals-inc Bayer Healthcare Pharmaceuticals Inc.
$58.0M · #43/1,925 · 0.4% industry · PY2024
- TOT $58.0M
- RANK #43
- SHARE 0.4%
- TXN 158,535
- RCP 146,928
- CAT 7
- GEN $11.5M
- ΔGEN −$302.5K
- TOP1 21.0%
- PY 2024
Volume peers
Nearest volume peer: Biogen, Inc. ($59.9M)
Bayer Healthcare Pharmaceuticals Inc. sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
Release-over-release change
General Payments changed from PY2023 to PY2024
Bayer Healthcare Pharmaceuticals Inc.'s CMS-reported General Payments decreased by $302.5K (−2.6%) from PY2023 to PY2024.
How this year-over-year comparison is scoped
The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.
CMS source labels for this exact identifier: PY2022: BAYER HEALTHCARE PHARMACEUTICALS INC.PY2023: BAYER HEALTHCARE PHARMACEUTICALS INC.PY2024: Bayer Healthcare Pharmaceuticals Inc.. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.
Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.
General Payments: PY2023 vs PY2024
Annual CMS-reported totals for this company, not an all-category Open Payments total
- PY2023
- $11,764,214.03
- PY2024
- $11,461,679.87
What the Data Shows for Bayer Healthcare Pharmaceuticals Inc.
The all-tracks total above combines three CMS reporting categories - General Payments, Research Payments, and Ownership/Investment interests - not one undifferentiated figure. For Bayer Healthcare Pharmaceuticals Inc., that total blends General Payments (day-to-day consulting, meals, travel and speaking fees, shown separately above) with Research and Ownership/Investment interest records, each governed by its own CMS reporting rules. CMS publishes each Program Year's data roughly 12 months after the reporting period ends, so this reflects the most recently released cycle; see our methodology for how the tracks are standardized and compared across companies.
The 7-category breakdown below covers general payments only (see our methodology for how research and ownership payments are reported separately). The largest general-payment category is "Food and Beverage" at $3.3M, accounting for 28.6% of this company's General Payments and 141,349 transactions.
General Payment Breakdown by Type
Across 7 types of general payments, Bayer Healthcare Pharmaceuticals Inc.'s largest category was "Food and Beverage" at $3.3M - 28.6% of General Payments.
Bayer Healthcare Pharmaceuticals Inc. reports 7 general-payment categories - the top three are Food and Beverage (28.6%), Compensation for Services Other Than Consulting (25.6%), and Grant (21.0%). The remaining 4 categories make up 24.8% of this company's reported general-payment total. That multi-category mix is the kind of profile single-category reporters cannot show.
How Bayer Healthcare Pharmaceuticals Inc. divides its payments
Top payment categories by total reported dollar volume
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Food and Beverage | $3.3M | 141,349 | 28.6% |
| Compensation for Services Other Than Consulting | $2.9M | 1,063 | 25.6% |
| Grant | $2.4M | 6 | 21.0% |
| Consulting Fee | $2.1M | 1,058 | 18.1% |
| Travel and Lodging | $562.4K | 1,580 | 4.9% |
| Space Rental or Facility Fees | $171.3K | 60 | 1.5% |
| Education | $36.7K | 1,812 | 0.3% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $2,936,613.11 (25.6%) of $11,461,679.87 in this company's General Payments records across 55,444 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Bayer Healthcare Pharmaceuticals Inc.
The five named recipients with the highest reported General Payments from this company
- 1
Brigham And Womens Hospital
$2,407,870.00 across 4 reported transactions
- 2
David Muram
$209,000.00 across 11 reported transactions
- 3
Ramon Mendez
$113,528.09 across 125 reported transactions
- 4
Lawrence Byrd
$110,281.13 across 83 reported transactions
- 5
Christian W Mende
$95,933.89 across 87 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Spend vs. Concentration
Bayer Healthcare Pharmaceuticals Inc. ranks #43 of 1,925 by total payments (top 2% by spend) but spreads that money notably more broadly than its spend rank alone would suggest -- #1,322 of 1,838 by HHI (bottom 28% least concentrated), a wider distribution than most similarly sized payers.
View all 12 companies in this HHI neighborhood as a list
- Cascination AG : $694.27 total payments, HHI 464
- Kite Pharma, Inc. : $1.3M total payments, HHI 462
- Musculoskeletal Transplant Foundation Inc. : $1.7M total payments, HHI 461
- MED-EL Corporation : $1.1M total payments, HHI 459
- Fusion Orthopedics USA, LLC : $655.1K total payments, HHI 458
- Dentsply LLC : $290.4K total payments, HHI 457
- Bayer Healthcare Pharmaceuticals Inc. (this company) : $11.5M total payments, HHI 456
- Invivyd Inc : $70.5K total payments, HHI 455
- DENTSPLY Canada Ltd : $22.0K total payments, HHI 452
- Molnlycke Health Care US, LLC : $392.2K total payments, HHI 451
- VOCO America Inc. : $189.4K total payments, HHI 451
- Think Surgical, Inc. : $103.4K total payments, HHI 450
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Bayer Healthcare Pharmaceuticals Inc.'s, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Bayer Healthcare Pharmaceuticals Inc..
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Bayer Healthcare Pharmaceuticals Inc..
Showing 6 of 1,924 companies with CMS-reported payment data.
Lilly USA, LLC
$54.3M 544,473 recipients
Compare payment profiles
Advanced Accelerator Applications
$63.9M 167 recipients
Compare payment profiles
US Retina LLC
$50.8M 8 recipients
Compare payment profiles
Smith+Nephew, Inc.
$50.5M 71,450 recipients
Compare payment profiles
Vektor Medical Inc.
$49.6M 56 recipients
Compare payment profiles
Put this to use
Bayer Healthcare Pharmaceuticals Inc. ranks #43 of 1,925 by all-tracks total payments, led by "Food and Beverage".
- See where Bayer Healthcare Pharmaceuticals Inc. sits among every top spender on the full leaderboard. Top 100 by total payments
- Compare "Food and Beverage" spend across every manufacturer, not just Bayer Healthcare Pharmaceuticals Inc.. Payment type breakdowns
- New to Open Payments? Learn what these figures do and do not show. Read the guide
Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.
Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.